z-logo
open-access-imgOpen Access
Synthesis and spectroscopic characterization of new solid solution containing Mg(II) and Cu(II) complexes with hexadentate 1,3-propanediaminen, N,N’,N’-tetraacetate (1,3-pdta) ligand: In vitro antifungal activity of 1,3-pdta-Cu(II) complexes
Author(s) -
Milenko Stanojević,
Jelena Gitarić,
P Darko Asanin,
Biljana Glisic Dj.,
S Nenad Draskovic,
Petar Zivkovic,
P. Vasić
Publication year - 2020
Publication title -
facta universitatis. series: physics, chemistry and technology
Language(s) - English
Resource type - Journals
eISSN - 2406-0879
pISSN - 0354-4656
DOI - 10.2298/fupct2001047s
Subject(s) - chemistry , ligand (biochemistry) , antifungal , crystallography , single crystal , crystal structure , nuclear chemistry , molar conductivity , medicinal chemistry , stereochemistry , elemental analysis , inorganic chemistry , receptor , medicine , biochemistry , dermatology
New solid solution containing Mg(II) and Cu(II) complexes with hexadentate 1,3-propanediamine-N,N,N?,N?-tetraacetate ligand (1,3-pdta), [Mg(H2O)6] [Mg0.5Cu0.5(1,3-pdta)].2H2O was synthesized and structurally characterized by elemental microanalyses, molar conductivity, and spectroscopic (IR and UV-Vis) measurements. The spectroscopic data of [Mg(H2O)6][Mg0.5Cu0.5(1,3-pdta)].2H2O were compared with those for [Mg(H2O)6][Cu(1,3-pdta)].2H2O complex of the known molecular structure determined by single-crystal X-ray diffraction analysis. In vitro growth inhibition activity of [Mg(H2O)6][Mg0.5Cu0.5(1,3-pdta)].2H2O and [Mg(H2O)6][Cu(1,3-pdta)].2H2O against Colletotrichum acutatum and their effects on this fungus sporulation level are investigated. The obtained results showed that the highest percentage of inhibition for mycelium growth was achieved at a concentration of 500 ?g/mL for the investigated complexes. The biological activities of the investigated complexes were compared with those for the commercial formulation of fungicide captan (Method 480 SC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here